Structure

InChI Key YUKARLAABCGMCN-PKLMIRHRSA-N
Smile Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C.Cl
InChI
InChI=1S/C20H25NO2S2.ClH/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23;/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23);1H/t16-;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H26ClNO2S2
Molecular Weight 412.02
AlogP 5.04
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 6.0
Polar Surface Area 40.54
Molecular species ZWITTERION
Aromatic Rings 2.0
Heavy Atoms 25.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR GABA transporter 1 inhibitor PubMed DailyMed Wikipedia

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anxiety 3 D001007 ClinicalTrials
Anxiety Disorders 3 D001008 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
25.55
Psychiatric disorders
15.18
General disorders and administration site conditions
13.51
Injury, poisoning and procedural complications
12.15
Musculoskeletal and connective tissue disorders
7.12
Eye disorders
3.87
Vascular disorders
3.35
Investigations
2.93
Gastrointestinal disorders
2.51
Immune system disorders
2.51

Cross References

Resources Reference
ChEBI 85388
ChEMBL CHEMBL1695
EPA CompTox DTXSID2044218
FDA SRS DQH6T6D8OY
Guide to Pharmacology 4818
KEGG C07503
PubChem 91274
SureChEMBL SCHEMBL41860
ZINC ZINC03831531